Swedencare Q1 Sales Rise, Profits Hit by Higher Costs

Key Q1 Financial Highlights

Swedencare AB reported first-quarter net sales of SEK 650 million, marking a 1% increase from the previous year and an 11% rise on an organic basis. The sales figures were in line with analyst expectations. Operational EBITDA grew by 3% year-on-year to SEK 128 million, though this result was 3% below consensus estimates.

Operational Performance Overview

The company's profitability faced pressure from rising external costs, notably expenses linked to Amazon sales and participation in multiple trade fairs. Strong growth momentum in Europe and Production helped balance softer sales volumes in the North American market. The Dental and Pharma product categories were standout performers, with sales increasing by 26% and 195% respectively.

Economic and Market Impact

The operational EBIT remained flat year-on-year at SEK 103 million, resulting in a slightly lower margin of 15.8% compared to 16.0% in the prior year. Sales for Nutraceuticals and Topicals & Dermatology saw declines, falling 15% and 12% respectively. Management indicated that underlying market demand remains stable and aims to normalize cost levels during the second half of the year.

Summary and Outlook

Despite meeting sales forecasts, Swedencare's first-quarter profitability was impacted by increased operational spending. The company's management is focused on mitigating these cost pressures and expressed confidence in stable market demand, setting a goal to normalize costs in the coming months.

FAQ

Q: What were Swedencare's total sales in the first quarter?
A: Swedencare reported Q1 net sales of SEK 650 million, a 1% increase year-on-year.

Q: Why were Swedencare's profits under pressure?
A: Profitability was affected by higher external costs, including Amazon-linked expenses and participation in several trade fairs.

Q: Which product segments performed best for Swedencare in Q1?
A: The Dental and Pharma segments showed the strongest performance, with sales growing 26% and 195% year-on-year, respectively.

Source: Investing.com